Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$567K Sell
34,850
-2,943
-8% -$52.5K ﹤0.01% 1050
2026
Q1
$720K Buy
37,793
+9,106
+32% +$176K 0.01% 863
2025
Q4
$470K Sell
28,687
-266
-0.9% -$4.68K ﹤0.01% 977
2025
Q3
$544K Sell
28,953
-3,560
-11% -$63.8K ﹤0.01% 943
2025
Q2
$657K Buy
32,513
+8,918
+38% +$154K 0.01% 851
2025
Q1
$324K Buy
23,595
+309
+1% +$4.25K ﹤0.01% 1073
2024
Q4
$276K Buy
23,286
+3,303
+17% +$52K ﹤0.01% 1158
2024
Q3
$358K Buy
19,983
+818
+4% +$14.9K ﹤0.01% 1035
2024
Q2
$337K Buy
19,165
+4,560
+31% +$94.2K ﹤0.01% 1020
2024
Q1
$375K Buy
14,605
+106
+0.7% +$2.66K ﹤0.01% 1022
2023
Q4
$378K Sell
14,499
-79
-0.5% -$1.8K ﹤0.01% 1014
2023
Q3
$336K Buy
14,578
+264
+2% +$6.62K ﹤0.01% 1012
2023
Q2
$336K Buy
+14,314
New +$243K ﹤0.01% 1026

Other funds holding XP

Xponance's XP Position: Q2 2026 in Review

Xponance reduced its XP (XP) stake by 7.8% in Q2 2026, selling an estimated $52.5K and leaving 34,850 shares worth $567K. The position accounts for ﹤0.01% of the portfolio, ranked #1050.

Xponance first reported a position in XP in Q2 2023 and has held it in 13 quarters since. The position peaked at $720K in Q1 2026. 320 funds tracked by Wall St. Rank hold XP as of Q2 2026.

  • Xponance held 34,850 shares of XP worth $567K as of Q2 2026.
  • Xponance sold 2,943 XP shares in Q2 2026, an estimated $52.5K.
  • XP made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1050 holding.
  • Xponance first reported a position in XP in Q2 2023 and has held it in 13 quarters since.
  • Xponance's XP position peaked at $720K in Q1 2026.
  • 320 funds tracked by Wall St. Rank held XP as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.